Involvement of heterogeneous nuclear ribonucleoproteins in viral multiplication

Future Virology

Volumn 7, Issue 6, 2012, Pages 575-591

  Castilla, Viviana ^a   Scolaro, Luis A ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

heterogeneous nuclear ribonucleoprotein; hnRNP; PCBP; PTB; replication; RNA; splicing; translation; virus

Indexed keywords

GENOMIC RNA; GUANOSINE TRIPHOSPHATASE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN C; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN E2; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN I; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN Q; NONSTRUCTURAL PROTEIN 5; PROTEIN P62; RAN PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AVIAN INFLUENZA VIRUS; CELL DIVISION; CELLULAR DISTRIBUTION; CORONAVIRUS; COXSACKIE VIRUS; DENGUE VIRUS; FLAVIVIRUS; GENE SILENCING; HERPES VIRUS; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; JAPANESE ENCEPHALITIS VIRUS; NONHUMAN; ORTHOMYXOVIRUS; PAPILLOMA VIRUS; PATHOGENESIS; PICORNAVIRUS; PICORNAVIRUS INFECTION; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; RHABDOVIRUS; RHINOVIRUS; RNA PROCESSING; RNA REPLICATION; RNA SPLICING; RNA SYNTHESIS; RNA TRANSLATION; SINDBIS VIRUS; TOGAVIRUS; VIROGENESIS; VIRUS REPLICATION;

ARENAVIRIDAE; CORONAVIRIDAE; FLAVIVIRIDAE; HERPESVIRIDAE; ORTHOMYXOVIRIDAE; PAPILLOMAVIRIDAE; PICORNAVIRIDAE; RETROVIRIDAE; RHABDOVIRIDAE; TOGAVIRIDAE;

EID: 84862008186     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl.12.48     Document Type: Review

References (115)

1. Dreyfuss G, Matunis MJ, Pinolroma S, Burd, CG. hnRNP proteins and the biogenesis of messenger-RNA. Annu. Rev. Biochem. 62, 289-321 (1993).
2. Han SP, Tang IH, Smith R. Functional diversity of the hnRNPs: past, present and perspectives. Biochem. J. 430(3), 379-392 (2010). Complete and updated review regarding the structure and cellular functions of most heterogeneous nuclear ribonucleoproteins (hnRNPs) described to date.
3. Chaudhury A, Chander P, Howe PH. Heterogeneous nuclear ribonucleoproteins (hnRNPs) in cellular processes: focus on hnRNP E1's multifunctional regulatory roles. RNA 16(8), 1449-1462 (2010).
4. Cheunim T, Zhang J, Milligan SG, McPhillips MG, Graham SV. The alternative splicing factor hnRNP A1 is up-regulated during virus-infected epithelial cell differentiation and binds the human papillomavirus type 16 late regulatory element. Virus Res. 131(2), 189-198 (2008).
5. Monette A, Ajamian L, López-Lastra M, Mouland AJ. Human immunodeficiency virus type 1 (HIV-1) induces the cytoplasmic retention of heterogeneous nuclear ribonucleoprotein A1 by disrupting nuclear import: implications for HIV-1 gene expression. J. Biol. Chem. 284(45), 31350-33162 (2009). Interesting article that accurately explores both the mechanism of cytoplasmic relocalization and the function of hnRNP A1 during HIV infection.
6. Maeto CA, Knott ME, Linero FN, Ellenberg PC, Scolaro LA, Castilla V. Differential effect of acute and persistent Junin virus infections on the nucleo-cytoplasmic trafficking and expression of heterogeneous nuclear ribonucleoproteins type A and B. J. Gen. Virol. 92(9), 2181-2190 (2011).
7. Belov GA, Evstafieva AG, Rubtsov YP, Mikitas OV, Vartapetian AB, Agol VI. Early alteration of nucleocytoplasmic traffic induced by some RNA viruses. Virology 275(2), 244-248 (2000).
8. Gustin KE, Sarnow P. Inhibition of nuclear import and alteration of nuclear pore complex composition by rhinovirus. J. Virol. 76(17), 8787-8796 (2002).
9. Gustin KE. Inhibition of nucleo-cytoplasmic trafficking by RNA viruses: targeting the nuclear pore complex. Virus Res. 95(1-2), 35-44 (2003).
10. Romanelli MG, Morandi C. Importin a binds to an unusual bipartite nuclear localization signal in the heterogeneous ribonucleoprotein type I. Eur. J. Biochem. 269(11), 2727-2734 (2002).
11. Park N, Katikaneni P, Skern T, Gustin KE. Differential targeting of nuclear pore complex proteins in poliovirus-infected cells. J. Virol. 82(4), 1647-1655 (2008).
12. Porter FW, Bochkov YA, Albee AJ, Wiese C, Palmenberg AC. A picornavirus protein interacts with Ran-GTPase and disrupts nucleocytoplasmic transport. Proc. Natl Acad. Sci. USA 103(33), 12417-12422 (2006).
13. Petersen JM, Her LS, Dahlberg JE. Multiple vesiculoviral matrix proteins inhibit both nuclear export and import. Proc. Natl Acad. Sci. USA 98(15), 8590-8595 (2001).
14. von Kobbe C, van Deursen JMA, Rodrigues JP et al. Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleopoin Nup98. Mol. Cell 6(5), 1243-1252 (2000).
15. Pettit Kneller EL, Connor JH, Lyles DS. hnRNPs relocalize to the cytoplasm following infection with vesicular stomatitis virus. J. Virol. 83(2), 770-780 (2009).
16. Faria PA, Chakraborty P, Levay A et al. VSV disrupts the Rae1/mrnp41 mRNA nuclear export pathway. Mol. Cell 17(1), 93-102 (2005).
17. Koloteva-Levine N, Amichay M, Elroy-Stein O. Interaction of hnRNP-C1/C2 proteins with RNA: analysis using the yeast three-hybrid system. FEBS Lett. 523(1-3), 73-78 (2002).
18. Brunner JE, Nguyen JH, Roehl HH, Ho TV, Swiderek KM, Semler BL. Functional interaction of heterogeneous nuclear ribonucleoprotein C with poliovirus RNA synthesis initiation complexes. J. Virol. 79(6), 3254-3266 (2005).
19. Ertel KJ, Brunner JE, Semler BL. Mechanistic consequences of hnRNP C binding to both RNA termini of poliovirus negative-strand RNA intermediates. J. Virol. 84(9), 4229-4242 (2010). Demonstrates the role of an hnRNP in the promotion of efficient poliovirus positive-strand RNA synthesis.
20. Brunner JE, Ertel KJ, Rozovics JM, Semler BL. Delayed kinetics of poliovirus RNA synthesis in a human cell line with reduced levels of hnRNP C proteins. Virology 400(2), 240-247 (2010).
21. Dejgaard K, Leffers H. Characterisation of the nucleic-acid binding activity of KH domains. Different properties of different domains. Eur. J. Biochem. 241(2), 425-431 (1996).
22. Gamarnik AV, Andino R. Two functional complexes formed by KH domain containing proteins with the 5′ noncoding region of poliovirus RNA. RNA 3(8), 882-892 (1997).
23. Kim JH, Hahm B, Kim YK, Choi M, Jang SK. Protein-protein interaction among hnRNPs shuttling between nucleus and cytoplasm. J. Mol. Biol. 298(3), 395-405 (2000).
24. Gamarnik AV, Andino R. Switch from translation to RNA replication in a positive-stranded RNA virus. Genes Dev. 12(15), 2293-2304 (1998).
25. Walter BL, Parsley TB, Ehrenfeld E, Semler BL. Distinct poly(rC) binding protein KH domain determinants for poliovirus translation initiation and viral RNA replication. J. Virol. 76(23), 12008-12022 (2002).
26. Barton DJ, O'Donnell BJ, Flanegan JB. 5′ cloverleaf in poliovirus RNA is a cis-acting replication element required for negative strand synthesis. EMBO J. 20(6), 1439-1448 (2001).
27. Herold J, Andino R. Poliovirus RNA replication requires genome circularization through a protein-protein bridge. Mol. Cell 7(3), 581-591 (2001).
28. Toyoda H, Franco D, Fujita K, Paul AV, Wimmer E. Replication of poliovirus requires binding of the poly(rC) binding protein to the cloverleaf as well as to the adjacent C-rich spacer sequence between the cloverleaf and the internal ribosomal entry site. J. Virol. 81(18), 10017-10028 (2007).
29. Sharma N, Ogram SA, Morasco BJ, Spear A, Chapman NM, Flanegan JB. Functional role of the 5′ terminal cloverleaf in Coxsackievirus RNA replication. Virology 393 (2), 238-249 (2009).
30. Bomsztyk K, Denisenko O, Ostrowski J. hnRNP K: one protein multiple processes. Bioessays 26(6), 629-638 (2004).
31. Lin JY, Li ML, Huang PN, Chien KY, Horng JT, Shih SR. Heterogeneous nuclear ribonuclear protein K interacts with the enterovirus 71 5′ untranslated region and participates in virus replication. J. Gen. Virol. 89(10), 2540-2549 (2008).
32. Shih SR, Stollar V, Li ML. Host factors in enterovirus 71 replication. J. Virol. 85(19), 9658-9666 (2011). Complete revision of the roles of different host factors, including hnRNPs, in the replication of enterovirus 71.
33. Paranjape SM, Harris E. Y box-binding protein-1 binds to the dengue virus 3′-untranslated region and mediates antiviral effects. J. Biol. Chem. 282(42), 30497-30508 (2007).
34. Agis-Juárez RA, Galván I, Medina F et al. Polypyrimidine tract-binding protein is relocated to the cytoplasm and is required during dengue virus infection in Vero cells. J. Gen. Virol. 90(12), 2893-2901 (2009).
35. Chang CJ, Luh HW, Wang SH, Lin HJ, Lee SC, Hu ST. The heterogeneous nuclear ribonucleoprotein K (hnRNP K) interacts with dengue virus core protein. DNA Cell Biol. 20(9), 569-577 (2001).
36. Noisakran S, Sengsai S, Thongboonkerd V et al. Identification of human hnRNP C1/C2 as a dengue virus NS1-interacting protein. Biochem. Biophys. Res. Commun. 372(1), 67-72 (2008).
37. Katoh H, Mori Y, Kambara H et al. Heterogeneous nuclear ribonucleoprotein A2 participates in the replication of Japanese encephalitis virus through an interaction with viral proteins and RNA. J. Virol. 85(21), 10976-10988 (2011). Constitutes a detailed analysis of the involvement of hnRNP A2 in different stages of the replication of the flavivirus Japanese encephalitis virus.
38. Wang L, Jeng KS, Lai MM. Poly(C)-binding protein 2 interacts with sequences required for viral replication in the hepatitis C virus (HCV) 5′ untranslated region and directs HCV RNA replication through circularizing the viral genome. J. Virol. 85(16), 7954-7964 (2011). Meticulous study that investigates the interaction of an hnRNP (PCBP2) with viral components and its relevance to virus replication.
39. Xin Z, Han W, Zhao Z et al. PCBP2 enhances the antiviral activity of IFN-α against HCV by stabilizing the mRNA of STAT1 and STAT2. PLoS One 6(10), e25419 (2011).
40. Ito T, Lai MMC. An internal polypyrimidine-tract-binding protein-binding site in the hepatitis C virus RNA attenuates translation, which is relieved by the 3V-untranslated sequence. Virology 254(2), 288-296 (1999).
41. Anwar A, Ali N, Tanveer R, Siddiqui A. Demonstration of functional requirement of polypyrimidine tract-binding protein by SELEX RNA during hepatitis C virus internal ribosome entry site mediated translation initiation. J. Biol. Chem. 275(44), 34231-34235 (2000).
42. Domitrovich AM, Diebel KW, Ali N, Sarker S, Siddiqui A. Role of La autoantigen and polypyrimidine tract-binding protein in HCV replication. Virology 335(1), 72-86 (2005).
43. Aizaki H, Choi KS, Liu M, Li YJ, Lai MM. Polypyrimidine-tract-binding protein is component of the HCV RNA replication complex and necessary for RNA synthesis. J. Biomed. Sci. 13(4), 469-480 (2006).
44. Liu HM, Aizaki H, Choi KS, Machida K, Ou JJ, Lai MM. SYNCRIP (synaptotagmin-binding, cytoplasmic RNA-interacting protein) is a host factor involved in hepatitis C virus RNA replication. Virology 386(2), 249-256 (2009).
45. Sola I, Galán C, Mateos-Gómez PA et al. The polypyrimidine tract-binding protein affects coronavirus RNA accumulation levels and relocalizes viral RNAs to novel cytoplasmic domains different from replication-transcription sites. J. Virol. 85(10), 5136-5149 (2011). Very interesting article that examines the participation of hnRNP I in the complex processes of coronavirus RNA replication and transcription.
46. Li HP, Huang P, Park S, Lai MM. Polypyrimidine tract-binding protein binds to the leader RNA of mouse hepatitis virus and serves as a regulator of viral transcription. J. Virol. 73(1), 772-777 (1999).
47. Huang P, Lai MM. Polypyrimidine tract-binding protein binds to the complementary strand of the mouse hepatitis virus 3′ untranslated region, thereby altering RNA conformation. J. Virol. 73(11), 9110-9116 (1999).
48. Choi KS, Huang P, Lai MM. Polypyrimidine-tract-binding protein affects transcription but not translation of mouse hepatitis virus RNA. Virology 303(1), 58-68 (2002).
49. Shi ST, Yu GY, Lai MM. Multiple type A/B heterogeneous nuclear ribonucleoproteins (hnRNPs) can replace hnRNP A1 in mouse hepatitis virus RNA synthesis. J. Virol. 77(19), 10584-10593 (2003).
50. Li HP, Zhang X, Duncan R, Comai L, Lai MM. Heterogeneous nuclear ribonucleoprotein A1 binds to the transcription-regulatory region of mouse hepatitis virus RNA. Proc. Natl Acad. Sci. USA 94(18), 9544-9549 (1997).
51. Shi ST, Huang P, Li HP, Lai MM. Heterogeneous nuclear ribonucleoprotein A1 regulates RNA synthesis of a cytoplasmic virus. EMBO J. 19(17), 4701-4711 (2000).
52. Shen X, Masters PS. Evaluation of the role of heterogeneous nuclear ribonucleoprotein A1 as a host factor in murine coronavirus discontinuous transcription and genome replication. Proc. Natl Acad. Sci. USA 98(5), 2717-2722 (2001).
53. Choi KS, Mizutani A, Lai MM. SYNCRIP, a member of the heterogeneous nuclear ribonucleoprotein family, is involved in mouse hepatitis virus RNA synthesis. J. Virol. 78(23), 13153-13162 (2004).
54. Galán C, Sola I, Nogales A et al. Host cell proteins interacting with the 3′ end of TGEV coronavirus genome influence virus replication. Virology 391(2), 304-314 (2009).
55. Burnham AJ, Gong L, Hardy RW. Heterogeneous nuclear ribonuclear protein K interacts with Sindbis virus nonstructural proteins and viral subgenomic mRNA. Virology 367(1), 212-221 (2007).
56. Lin JY, Shih SR, Pan M et al. hnRNP A1 interacts with the 5′ untranslated regions of enterovirus 71 and Sindbis virus RNA and is required for viral replication. J. Virol. 83(12), 6106-6114 (2009).
57. Gui H, Lu CW, Adams S, Stollar V, Li ML. hnRNP A1 interacts with the genomic and subgenomic RNA promoters of Sindbis virus and is required for the synthesis of G and SG RNA. J. Biomed. Sci. 17, 59 (2010).
58. Dinh PX, Beura LK, Panda D, Das A, Pattnaik AK. Antagonistic effects of cellular poly(C) binding proteins on vesicular stomatitis virus gene expression. J. Virol. 85(18), 9459-9471 (2011).
59. Jorba N, Juarez S, Torreira E, Gastaminza P, Zamarreño N, Albar JP, Ortín J. Analysis of the interaction of influenza virus polymerase complex with human cell factors. Proteomics 8(10), 2077-2088 (2008).
60. Lee JH, Kim SH, Pascua PN et al. Direct interaction of cellular hnRNP-F and NS1 of influenza A virus accelerates viral replication by modulation of viral transcriptional activity and host gene expression. Virology 397(1), 89-99 (2010).
61. Jablonski JA, Caputi M. Role of cellular RNA processing factors in human immunodeficiency virus type 1 mRNA metabolism, replication, and infectivity. J. Virol. 83(2), 981-992 (2009). Investigates the role of different RNA processing factors, including hnRNPs, in mRNA processing during HIV replication.
62. Walter BL, Nguyen JH, Ehrenfeld E, Semler BL. Differential utilization of poly(rC) binding protein 2 in translation directed by picornavirus IRES elements. RNA 5(12), 1570-1585 (1999).
63. Blyn LB, Towner JS, Semler BL, Ehrenfeld E. Requirement of poly(rC) binding protein 2 for translation of poliovirus RNA. J. Virol. 71(8), 6243-6246 (1997).
64. Sean P, Nguyen JH, Semler BL. The linker domain of poly(rC) binding protein 2 is a major determinant in poliovirus cap-independent translation. Virology 378(2), 243-253 (2008).
65. Hunt SL, Jackson RJ. Polypyrimidine-tract-binding protein (PTB) is necessary, but not sufficient, for efficient internal initiation of translation of human rhinovirus-2 RNA. RNA 5(3), 344-359 (1999).
66. Gosert R, Chang KH, Rijnbrand R, Yi M, Sangar DV, Lemon SM. Transient expression of cellular polypyrimidine-tract binding protein stimulates cap-independent translation directed by both picornaviral and flaviviral internal ribosome entry sites in vivo. Mol. Cell Biol. 20(5), 1583-1595 (2000).
67. Niepmann M, Petersen A, Meyer K, Beck E. Functional involvement of polypyrimidine-tract-binding protein in translation initiation complexes with the internal ribosome entry site of foot-and mouth disease virus. J. Virol. 71(11), 8330-8339 (1997).
68. Kaminski A, Jackson RJ. The polypyrimidine-tract binding protein (PTB) requirement for internal initiation of translation of cardiovirus RNAs is conditional rather than absolute. RNA 4(6), 626-638 (1998).
69. Kafasla P, Morgner N, Robinson CV, Jackson RJ. Polypyrimidine tract-binding protein stimulates the poliovirus IRES by modulating eIF4G binding. EMBO J. 29(21) 3710-3722 (2010). Constitutes a meticulous study on the mechanism of hnRNP modulation of the poliovirus internal ribosome entry site-dependent translation process.
70. Cammas A, Pileur F, Bonnal S et al. Cytoplasmic relocalization of heterogeneous nuclear ribonucleoprotein A1 controls translation initiation of specific mRNAs. Mol. Biol. Cell 18(12), 5048-5059 (2007).
71. Fukushi S, Okada M, Kageyama T, Hoshino FB, Nagai K, Katayama K. Interaction of poly(rC)-binding protein 2 with the 5′-terminal stem loop of the hepatitis C-virus genome. Virus Res. 73(1), 67-79 (2001).
72. Murray KE, Roberts AW, Barton DJ. Poly(rC) binding proteins mediate poliovirus mRNA stability. RNA 7(8), 1126-1141 (2001).
73. Fontanes V, Raychaudhuri S, Dasgupta A. A cell-permeable peptide inhibits hepatitis C virus replication by sequestering IRES transacting factors. Virology 394(1), 82-90 (2009).
74. Kim JH, Paek KY, Ha SH et al. A cellular RNA-binding protein enhances internal ribosomal entry site-dependent translation through an interaction downstream of the hepatitis C virus polyprotein initiation codon. Mol. Cell Biol. 24(18), 7878-7890 (2004).
75. Park SM, Paek KY, Hong KY et al. Translation-competent 48S complex formation on HCV IRES requires the RNA-binding protein NSAP1. Nucleic Acids Res. 39(17), 7791-7802 (2011).
76. Hwang B, Lim JH, Hahm B, Jang SK, Lee SW. hnRNP L is required for the translation mediated by HCV IRES. Biochem. Biophys. Res. Commun. 378(3), 584-588 (2009).
77. Paek KY, Kim CS, Park SM, Kim JH, Jang SK. RNA-binding protein hnRNP D modulates internal ribosome entry site-dependent translation of hepatitis C virus RNA. J. Virol. 82(24), 12082-12093 (2008).
78. Bolinger C, Boris-Lawrie K. Mechanisms employed by retroviruses to exploit host factors for translational control of a complicated proteome. Retrovirology 6, 8 (2009).
79. Hadian K, Vincendeau M, Mäusbacher N et al. Identification of a heterogeneous nuclear ribonucleoprotein-recognition region in the HIV Rev protein. J. Biol. Chem. 284(48), 33384-33391 (2009).
80. Lund N, Milev MP, Wong R et al. Differential effects of hnRNP D/AUF1 isoforms on HIV-1 gene expression. Nucleic Acids Res. doi:10.1093/nar/gkr1238 (2011) (Epub ahead of print).
81. Woolaway K, Asai K, Emili A, Cochrane A. hnRNP E1 and E2 have distinct roles in modulating HIV-1 gene expression. Retrovirology 4, 28 (2007).
82. Schaub MC, Lopez SR, Caputi M. Members of the heterogeneous nuclear ribonucleoprotein H family activate splicing of an HIV-1 splicing substrate by promoting formation of ATP-dependent spliceosomal complexes. J. Biol. Chem. 282(18), 13617-13626 (2007).
83. Okunola HL, Krainer AR. Cooperative-binding and splicing-repressive properties of hnRNP A1. Mol. Cell Biol. 29(20), 5620-5631 (2009).
84. Najera I, Krieg M, Karn J. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1. J. Mol. Biol. 285(5), 1951-1964 (1999).
85. Dodon MD, Hamaia S, Martin J, Gazzolo L. Heterogeneous nuclear ribonucleoprotein A1 interferes with the binding of the human T cell leukemia virus type 1 rex regulatory protein to its response element. J. Biol. Chem. 277(21), 18744-18752 (2002).
86. Milligan SG, Veerapraditsin T, Ahamet B, Mole S, Graham SV. Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells. Virology 360(1), 172-181 (2007).
87. Schwartz S. HPV-16 RNA processing. Front. Biosci. 13, 5880-5891 (2008).
88. Sanford JR, Ellis J, Cáceres JF. Multiple roles of arginine/serine-rich splicing factors in RNA processing. Biochem. Soc. Trans. 33(3), 443-446 (2005).
89. Zhao X, Fay J, Lambkin H, Schwartz S. Identification of a 17-nucleotide splicing enhancer in HPV-16 L1 that counteracts the effect of multiple hnRNP A1-binding splicing silencers. Virology 369(2), 351-363 (2007).
90. Oberg D, Fay J, Lambkin H, Schwartz S. A downstream polyadenylation element in human papillomavirus type 16 L2 encodes multiple GGG motifs and interacts with hnRNP H. J. Virol. 79(14), 9254-9269 (2005).
91. Somberg M, Zhao X, Fröhlich M, Evander M, Schwartz S. Polypyrimidine tract binding protein induces human papillomavirus type 16 late gene expression by interfering with splicing inhibitory elements at the major late 5′ splice site, SD3632. J. Virol. 82(7), 3665-3678 (2008). Describes the role of an hnRNP (PTB) as a splicing factor that controls late gene expression of HPV16 and its association with latent infection.
92. Bériault V, Clément JF, Lévesque K et al. A late role for the association of hnRNP A2 with the HIV-1 hnRNP A2 response elements in genomic RNA, Gag, and Vpr localization. J. Biol. Chem. 279(42), 44141-44153 (2004).
93. Lévesque K, Halvorsen M, Abrahamyan L et al. Trafficking of HIV-1 RNA is mediated by heterogeneous nuclear ribonucleoprotein A2 expression and impacts on viral assembly. Traffic 7(9), 1177-1193 (2006).
94. Schmidt T, Striebinger H, Haas J, Bailer SM. The heterogeneous nuclear ribonucleoprotein K is important for Herpes simplex virus-1 propagation. FEBS Lett. 584(20), 4361-4365 (2010).
95. Kanlaya R, Pattanakitsakul SN, Sinchaikul S, Chen ST, Thongboonkerd V. Vimentin interacts with heterogeneous nuclear ribonucleoproteins and dengue nonstructural protein 1 and is important for viral replication and release. Mol. Biosyst. 6(5), 795-806 (2010).
96. Bailey D, Karakasiliotis I, Vashist S et al. Functional analysis of RNA structures present at the 3′ extremity of the murine norovirus genome: the variable polypyrimidine tract plays a role in viral virulence. J. Virol. 84(6), 2859-2870 (2010).
97. Guest S, Pilipenko E, Sharma K, Chumakov K, Roos RP. Molecular mechanisms of attenuation of the Sabin strain of poliovirus type 3. J. Virol. 78(20), 11097-11107 (2004).
98. Bortz E, Westera L, Maamary J et al. Host- and strain-specific regulation of influenza virus polymerase activity by interacting cellular proteins. MBio 2, e00151-e00161(2011).
99. Zhao X, Rush M and Schwartz S. Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene. J. Virol. 78(20), 10888-108905 (2004).
100. Baccala R, Gonzalez-Quintial R, Lawson BR, Stern ME, Kono DH, Beutler B et al. Sensors of the innate immune system: their mode of action. Nat. Rev. Rheumatol. 5(8), 448-456 (2009).
101. Thompson MR, Kaminski JJ, Kurt-Jones EA, Fitzgerald KA. Pattern recognition receptors and the innate immune response to viral infection. Viruses 3(6), 920-940 (2011).
102. Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 5(5), 375-386 (2005).
103. Yao L, Yan X, Dong H, Nelson DR, Liu C, Li X. Expression of an IRF-3 fusion protein and mouse estrogen receptor, inhibits hepatitis C viral replication in RIG-I-deficient Huh 7.5 cells. Virol. J. 21(8), 445 (2011).
104. Shabman RS, Gulcicek EE, Stone KL, Basler CF. The Ebola virus VP24 protein prevents hnRNP C1/C2 binding to karyopherin a1 and partially alters its nuclear import. J. Infect. Dis. 204(Suppl. 3), S904-S910 (2011).
105. Beura LK, Dinh PX, Osorio FA, Pattnaik A. Cellular poly(c) binding proteins 1 and 2 interact with porcine reproductive and respiratory syndrome virus nonstructural protein 1b and support viral replication. J. Virol. 85(24), 12939-12949 (2011).
106. Das S, Ward SV, Markle D, Samuel CE. DNA damage-binding proteins and heterogeneous nuclear ribonucleoprotein A1 function as constitutive KCS element components of the interferon-inducible RNA-dependent protein kinase promoter. J. Biol. Chem. 279(8), 7313-7321 (2004).
107. Dhar D, Venkataramana M, Ponnuswamy A, Das S. Role of polypyrimidine tract binding protein in mediating internal initiation of translation of interferon regulatory factor 2 RNA. PLoS One 4(9), 7049 (2009).
108. Söderberg M, Raffalli-Mathieu F, Lang MA. Identification of a regulatory cis-element within the 3′-untranslated region of the murine inducible nitric oxide synthase (iNOS) mRNA; interaction with heterogeneous nuclear ribonucleoproteins I and L and role in the iNOS gene expression. Mol. Immunol. 44(4), 434-442 (2007).
109. Gaudreau MC, Heyd F, Bastien R, Wilhelm B, Möröy T. Alternative splicing controlled by heterogeneous nuclear ribonucleoprotein L regulates development, proliferation, and migration of thymic pre-T cells. J. Immunol. doi:10.4049/jimmunol.1103142 (2012) (Epub ahead of print).
110. Motta-Mena LB, Smith SA, Mallory MJ, Jackson J, Wang J, Lynch KW. A disease-associated polymorphism alters splicing of the human CD45 phosphatase gene by disrupting combinatorial repression by heterogeneous nuclear ribonucleoproteins (hnRNPs). J. Biol. Chem. 286(22), 20043-20053 (2011).
111. Triboulet R, Mari B, Lin Y-L et al. Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 315(5818), 1579-1582 (2007).
112. Gregory RI, Yan K, Amuthan G, Chendrimada T, Doratotaj B et al. The Microprocessor complex mediates the genesis of microRNAs. Nature 432(7014), 235-240 (2004).
113. Buratti E, Baralle FE. The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation. RNA Biol. 7(4), 420-429 (2010).
114. Saumet A, Lecellier C-H. Anti-viral RNA silencing: do we look like plants? Retrovirology 3, 3 (2006).
115. Chiang K, Rice AP. Mini ways to stop a virus: microRNAs and HIV-1 replication Future Virol. 6(2), 209-221 (2011).